Stock Scorecard
Stock Summary for Royalty Pharma plc - Class A (RPRX) - $32.70 as of 5/30/2025 5:54:18 PM EST
Total Score
13 out of 30
Safety Score
64 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for RPRX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RPRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RPRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RPRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RPRX (64 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 10 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RPRX
Financial Details for RPRX
Company Overview |
|
|---|---|
| Ticker | RPRX |
| Company Name | Royalty Pharma plc - Class A |
| Country | USA |
| Description | Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 32.70 |
| Price 4 Years Ago | 36.52 |
| Last Day Price Updated | 5/30/2025 5:54:18 PM EST |
| Last Day Volume | 2,377,080 |
| Average Daily Volume | 4,595,565 |
| 52-Week High | 34.31 |
| 52-Week Low | 23.73 |
| Last Price to 52 Week Low | 37.80% |
Valuation Measures |
|
| Trailing PE | 13.37 |
| Industry PE | 21.58 |
| Sector PE | 40.42 |
| 5-Year Average PE | 13.59 |
| Free Cash Flow Ratio | 12.67 |
| Industry Free Cash Flow Ratio | 17.23 |
| Sector Free Cash Flow Ratio | 31.66 |
| Current Ratio Most Recent Quarter | 1.56 |
| Total Cash Per Share | 2.58 |
| Book Value Per Share Most Recent Quarter | 15.72 |
| Price to Book Ratio | 2.06 |
| Industry Price to Book Ratio | 34.25 |
| Sector Price to Book Ratio | 29.96 |
| Price to Sales Ratio Twelve Trailing Months | 8.12 |
| Industry Price to Sales Ratio Twelve Trailing Months | 150.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 40.56 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 421,371,000 |
| Market Capitalization | 13,778,831,700 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 5/16/2025 |
| Previous Dividend Amount | 0.2200 |
| Current Dividend Amount | 0.2200 |
| Total Years Dividend Increasing | 5 |
| Trailing Annual Dividend Rate | 0.86 |
| Trailing Annual Dividend Yield | 2.63% |
| Forward Annual Dividend Rate | 0.88 |
| Forward Annual Dividend Yield | 2.69% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.34% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 4.76% |
| 3-Year Dividend Growth Rate Percentage | 2.35% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 7.30% |
| Dividend Payout Ratio | 35.10% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 5,056.00% |
| Annual Earnings Growth | -24.31% |
| Reported EPS 12 Trailing Months | 2.44 |
| Reported EPS Past Year | 1.06 |
| Reported EPS Prior Year | 4.10 |
| Net Income Twelve Trailing Months | 1,092,340,000 |
| Net Income Past Year | 859,000,000 |
| Net Income Prior Year | 1,134,834,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 4.53% |
| Operating Margin Twelve Trailing Months | 94.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,087,720,000 |
| Total Cash Past Year | 929,026,000 |
| Total Cash Prior Year | 477,010,000 |
| Net Cash Position Most Recent Quarter | -5,531,127,000 |
| Net Cash Position Past Year | -5,685,627,000 |
| Long Term Debt Past Year | 6,614,653,000 |
| Long Term Debt Prior Year | 6,135,285,000 |
| Total Debt Most Recent Quarter | 6,618,847,000 |
| Equity to Debt Ratio Past Year | 0.51 |
| Equity to Debt Ratio Most Recent Quarter | 0.50 |
| Total Stockholder Equity Past Year | 6,946,581,000 |
| Total Stockholder Equity Prior Year | 6,526,497,000 |
| Total Stockholder Equity Most Recent Quarter | 6,688,647,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,121,084,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.66 |
| Free Cash Flow Past Year | 2,768,986,000 |
| Free Cash Flow Prior Year | 872,280,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.15 |
| MACD Signal | 0.22 |
| 20-Day Bollinger Lower Band | 30.21 |
| 20-Day Bollinger Middle Band | 32.19 |
| 20-Day Bollinger Upper Band | 34.18 |
| Beta | 0.48 |
| RSI | 49.97 |
| 50-Day SMA | 28.64 |
| 150-Day SMA | 30.80 |
| 200-Day SMA | 32.17 |
System |
|
| Modified | 5/29/2025 9:46:28 AM EST |